Akebia Therapeutics's total assets for Q4 2024 were $220.67M, an increase of 6.53% from the previous quarter. AKBA total liabilities were $269.86M for the fiscal quarter, a 4.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.